Global inflation threatens progress on neglected disease innovation despite increase in private sector funding

Policy Cures Research’s new G-FINDER report shows that, after years of relative stability, funding for neglected disease R&D fell by 10% from 2021 to 2022, largely as a result of high inflation in 2022. This limits product developers’ ability to deliver on planned activities and may slow down collective progress in bringing much needed innovations to countries around the world.